Login to Your Account


Baxter follows Abbvie playbook: Split to boost collaboration or competition with biotechs?

By Marie Powers
Staff Writer

Friday, March 28, 2014
Baxter International Inc. emphasized “solid growth opportunities” in revealing its plan to create separate, independent global health care companies, with one focused on the development and commercialization of biopharmaceuticals and the other on medical products.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription